Phase III studies are performed after preliminary information suggesting effectiveness of the drug has been obtained.
They are intended to gather the additional information on the drug’s safety and effectiveness that is needed to:
- Evaluate the overall benefit-risk relationship of the drug
- Determine whether or not the drug is marketable
- The information which is necessary for the labeling of the product